Modular Medical, Inc.
Close on Oct 19, 2026
- Market cap
- $11.29M
- P/E (TTM)
- –
- Dividend yield
- –
About Modular Medical
Surgical & Medical Instruments & Apparatus, SIC 3841
Modular Medical, Inc. is a medical device company focused on the design, development, and commercialization of patch insulin pumps. The company develops tubeless, wearable insulin delivery systems designed to improve user convenience and broaden access to pump therapy. Its main product is the Pivot insulin delivery system, a three-part removable patch pump comprising a reusable pumping system, a disposable cartridge, and an infusion set. Through simplified one-button operation and low-cost manufacturing, the company seeks to address both Type 1 and Type 2 diabetes markets, serving patients requiring multiple daily insulin administrations.
The company operates within the United States medical technology sector. It maintains principal executive offices in San Diego, California. Modular Medical conducts its corporate administration, research, product development, and cartridge manufacturing activities from its domestic facilities, with plans to expand commercial distribution across metropolitan regions.
Summary of the business section of Modular Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Modular Medical, Inc.
- Headquarters
- San Diego, CA
- Address
- 10740 Thornmint Road 92127
- Phone
- (858) 800-3500
- Employees
- 51, Mar 31, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- March 31
- Auditor
- Farber Hass Hurley LLP, Chatsworth, California
Stock & identifiers
- Ticker
- MODD
- Exchange
- Nasdaq
- IPO date
- Feb 10, 2022
- Shares outstanding
- 8M, Aug 14, 2026
- Public float
- $37.45M, Sep 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-30 reverse, Jun 29, 2026; 1-for-30 reverse, Mar 31, 2026; 1-for-3 reverse, Feb 14, 2022
- SEC CIK
- 1074871
- CUSIP
- 60785L306
- ISIN
- US60785L3069
- EIN
- 87-0620495
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Management Co Llc Manchester | Chief Executive Officer, Director | 3,429,493 |
| Paul DiPerna | See Remarks | 5,097,171 |
| Kevin Schmid | Chief Operating Officer | – |
| James E. Besser | Chief Executive Officer | 5,800,000 |
| Steven G. Felsher | Director | 8,498 |
| Jeff D. Goldberg | Director | – |
| Carmen B. Volkart | Director | 916 |
| Philip Brent Sheibley | Director | 97,513 |
| Ellen O'Connor Vos | Director | 61,562 |
| Duane M. DeSisto | Director | 8,627 |
| Morgan C. Frank | Director | 206,226 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2024 | $130.48K | $420.39K | $446.65K | $-9 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of March 31, 2026, we had 51 employees, all located in the United States”
Corporate history
Events identified from SEC filings